Post-earnings recap
Reported
Thu, Jul 23, 2026
EPS actual
$6.12
EPS est.
$4.08
EPS surprise
+50.00%
1-day move
+1.88%
Tenet Healthcare reported a strong earnings per share figure, significantly beating expectations. The stock reacted positively, rising by 1.88%. However, without revenue figures or management commentary, the overall context of these results remains unclear.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $6.12 | N/A | +50.00% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
Tenet Healthcare Corporation (THC) operates in the health care sector, focusing on health care facilities. As a major player in the industry, its performance can reflect broader trends in health care spending and patient care services.
Last quarter
In Q1-2026, Tenet Healthcare reported an EPS of $4.82, exceeding expectations by 14.38%. However, the stock experienced a slight decline of 1.65% the following day.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+26.94%
Avg 1-day reaction
+2.58%
Investors are cautiously optimistic about Tenet's upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of specific guidance raises uncertainty.
Bull case
If Tenet continues its trend of beating EPS estimates, it could lead to a positive market reaction and boost investor confidence.
Bear case
On the other hand, if the company fails to meet expectations or provides weak guidance, it could lead to a significant decline in stock price.
The print will turn on these.
Q1
What will the EPS be for Q2-2026?
Given Tenet's history of exceeding EPS estimates, this number will be crucial for market sentiment.
Q2
How has patient volume changed compared to previous quarters?
Changes in patient volume can significantly impact revenue and overall business performance.
—
Est. EPS
$1.57
Est. Rev
$876M
Impl. Move
±13.5%
Why consensus could be wrong
The Street may be underestimating the impact of increased patient volume on Tenet's revenue, which could lead to stronger-than-expected earnings.
Supporting evidence
Tenet has consistently beaten EPS estimates, suggesting its operational efficiency is improving.
The options market is pricing a smaller move than historical averages, indicating potential for a surprise.
Recent trends in health care spending indicate a rebound that could benefit Tenet.
Key risk
If patient volume exceeds expectations, it could significantly alter the earnings outlook.
Pre-commit to what would confirm each case.
The market is debating whether Tenet can maintain its strong earnings performance amid rising costs and competition.
Bull confirmed if
An EPS of $5.00 or higher would confirm the bull case and suggest strong operational performance.
Bear confirmed if
An EPS below $4.50 would support the bear case, indicating potential issues in profitability.
What the market is pricing for the move.
Implied Move
±5.56%
Historical Avg
±9.3%
The options market is pricing in a move of about 5.56%, suggesting that traders expect some volatility around the earnings announcement.
Options are pricing ±5.6% while THC has averaged ±9.3% over the last 8 prints — setup is pricing cheap.
ATM IV
0.5%
30d HV
40.9%
Smart-money positioning from the most recent 13F filings.
Institutional
101.99%
of float
Insider
0.97%
of float
Holders
896
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
8,743,005 sh · $2.3B
10.86%
0.4%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Tenet beats expectations, history suggests the stock could rise by about 2.95%, confirming the company's strong operational capabilities.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with historical patterns indicating a potential drop of around 9.90% in the following days.
The lines on the call that would change the story.
Price (T.Rowe) Associates Inc
7,957,449 sh · $2.1B
9.88%
5.8%
Boston Partners
4,433,360 sh · $1.2B
5.51%
15.6%
Vanguard Portfolio Management LLC
4,238,108 sh · $1.1B
5.26%
-1.8%
FMR, LLC
3,994,545 sh · $1.0B
4.96%
-48.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.